138 related articles for article (PubMed ID: 11019386)
1. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K
Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386
[TBL] [Abstract][Full Text] [Related]
2. [The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A
Jpn J Antibiot; 1997 Oct; 50(10):829-43. PubMed ID: 9412873
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Fukuyama M; Kawakami K; Suda O; Imagawa Y
Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
Fukuyama M; Oonaka K; Hara M; Imagawa Y
Kansenshogaku Zasshi; 1996 Jan; 70(1):51-9. PubMed ID: 8822053
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
Imagawa Y; Fukuyama M; Kawakami K; Suda O
Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antibacterial activity of norfloxacin (NFLX) against enteritis-causing bacteria].
Goto N; Horiuchi S; Okamura N; Inagaki Y; Ozawa K; Mochizuki A; Nakaya R
Kansenshogaku Zasshi; 1986 Apr; 60(4):315-21. PubMed ID: 3095460
[No Abstract] [Full Text] [Related]
8. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter, Salmonella, Shigella and Escherichia coli in live and dressed poultry from metropolitan accra.
Sackey BA; Mensah P; Collison E; Sakyi-Dawson E
Int J Food Microbiol; 2001 Dec; 71(1):21-8. PubMed ID: 11764888
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Nasu T; Okamoto K; Nakanishi T; Nishino T
Jpn J Antibiot; 1999 Aug; 52(8):541-53. PubMed ID: 10587879
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Chida T; Nakaya R
Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
[TBL] [Abstract][Full Text] [Related]
15. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
16. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
Miyauchi K; Yoshida T; Kasai T; Saito T; Hirano H
Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
[TBL] [Abstract][Full Text] [Related]
17. Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt.
Wasfy MO; Oyofo BA; David JC; Ismail TF; el-Gendy AM; Mohran ZS; Sultan Y; Peruski LF
J Health Popul Nutr; 2000 Jun; 18(1):33-8. PubMed ID: 11014768
[TBL] [Abstract][Full Text] [Related]
18. [In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria].
Horiuchi S; Inagaki Y; Yamamoto N; Ogawa M; Nakaya R
Kansenshogaku Zasshi; 1992 Jan; 66(1):51-8. PubMed ID: 1402063
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and clinical studies on norfloxacin in the pediatric field].
Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M
Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
